Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study
Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex...
Gespeichert in:
Veröffentlicht in: | The Lancet infectious diseases 2015-08, Vol.15 (8), p.913-921 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 921 |
---|---|
container_issue | 8 |
container_start_page | 913 |
container_title | The Lancet infectious diseases |
container_volume | 15 |
creator | Baker, Kate S, PhD Dallman, Timothy J, PhD Ashton, Philip M, PhD Day, Martin, BSc Hughes, Gwenda, PhD Crook, Paul D, MSc Gilbart, Victoria L, MSc Zittermann, Sandra, PhD Allen, Vanessa G, MD Howden, Benjamin P, Prof Tomita, Takehiro, PhD Valcanis, Mary, MPH Harris, Simon R, PhD Connor, Thomas R, PhD Sintchenko, Vitali, PhD Howard, Peter, BSc Brown, Jeremy D, MBBS Petty, Nicola K, PhD Gouali, Malika, PharmD Thanh, Duy Pham, MSc Keddy, Karen H, BSc (Med) Smith, Anthony M, PhD Talukder, Kaisar A, PhD Faruque, Shah M, PhD Parkhill, Julian, Prof Baker, Stephen, Prof Weill, François-Xavier, PhD Jenkins, Claire, PhD Thomson, Nicholas R, Prof |
description | Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex with men (MSM), in whom transmission is an important component of shigellosis epidemiology in high-income nations. We aimed to use sophisticated subtyping and international sampling to determine factors driving shigellosis emergence in MSM linked to an outbreak in the UK. Methods We did a large-scale, cross-sectional genomic epidemiological study of shigellosis cases collected from 29 countries between December, 1995, and June 8, 2014. Focusing on an ongoing epidemic in the UK, we collected and whole-genome sequenced clinical isolates of Shigella flexneri serotype 3a from high-risk and low-risk regions, including cases associated with travel and sex between men. We examined relationships between geographical, demographic, and clinical patient data with the isolate antimicrobial susceptibility, genetic data, and inferred evolutionary relationships. Findings We obtained 331 clinical isolates of S flexneri serotype 3a, including 275 from low-risk regions (44 from individuals who travelled to high-risk regions), 52 from high-risk regions, and four outgroup samples (ie, closely related, but genetically distinct isolates used to determine the root of the phylogenetic tree). We identified a recently emerged lineage of S flexneri 3a that has spread intercontinentally in less than 20 years throughout regions traditionally at low risk for shigellosis via sexual transmission in MSM. The lineage had acquired multiple antimicrobial resistance determinants, and prevailing sublineages were strongly associated with resistance to the macrolide azithromycin. Eight (4%) of 206 isolates from the MSM-associated lineage were obtained from patients who had previously provided an isolate; these serial isolations indicated atypical infection patterns (eg, reinfection). Interpretation We identified transmission-facilitating behaviours and atypical course(s) of infection as precipitating factors in shigellosis-affected MSM. The intercontinental spread of antimicrobial-resistant shigella through established transmission routes emphasises the need for new approaches to tackle the public health challenge of sexually transmitted infections in MSM. Funding Wellcome Trust (grant number 098051) |
doi_str_mv | 10.1016/S1473-3099(15)00002-X |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_pasteur_02042957v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S147330991500002X</els_id><sourcerecordid>3773071011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c655t-292ecc93f31e0299f0b0a1aa7624ebc26d6daf3df4831cc5c9ecfe9af8ddd52c3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhiMEoh_wE0CRuJRDwB9xUnMAVRXQSitxAKS9WV570nXJ2luPU5H-epykFKkXfIkdP_MkM29RvKLkHSW0ef-d1i2vOJHyhIq3JC9WrZ8Uh_l1XdW1aJ_O-wU5KI4QrwmhLSX18-KACcmbhtLDYrz0CaIJPjkPPum-tA4Rds7r5IIvQ1fqO5e2MexG43wVAR0m7VOJW3cFfR_yuZzuh6ttifB7yIoUtcdd9mTDh1KXJgbECsFMynyPabDji-JZp3uEl_fP4-Lnl88_zi-q1bevl-dnq8o0QqSKSQbGSN5xCoRJ2ZEN0VTrtmE1bAxrbGN1x21Xn3JqjDASTAdSd6fWWsEMPy6qxbvVvdpHt9NxVEE7dXG2UnuNCYaoCCM1k6K9pZk_Wfh9DDcDYFK5E5M71R7CgIq2hHJKZDuhbx6h12GIucOZYi2pWyIyJRZqHkOE7uEvKFFTlmrOUk1BKSrUnKVa57rX9_ZhswP7UPU3vAx8WgDI47t1EBUaB96AdTHPWtng_vuJj48MpnfeGd3_ghHwXzcKmSKLZHJQMRvW_A-uGMdB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1702704705</pqid></control><display><type>article</type><title>Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Baker, Kate S, PhD ; Dallman, Timothy J, PhD ; Ashton, Philip M, PhD ; Day, Martin, BSc ; Hughes, Gwenda, PhD ; Crook, Paul D, MSc ; Gilbart, Victoria L, MSc ; Zittermann, Sandra, PhD ; Allen, Vanessa G, MD ; Howden, Benjamin P, Prof ; Tomita, Takehiro, PhD ; Valcanis, Mary, MPH ; Harris, Simon R, PhD ; Connor, Thomas R, PhD ; Sintchenko, Vitali, PhD ; Howard, Peter, BSc ; Brown, Jeremy D, MBBS ; Petty, Nicola K, PhD ; Gouali, Malika, PharmD ; Thanh, Duy Pham, MSc ; Keddy, Karen H, BSc (Med) ; Smith, Anthony M, PhD ; Talukder, Kaisar A, PhD ; Faruque, Shah M, PhD ; Parkhill, Julian, Prof ; Baker, Stephen, Prof ; Weill, François-Xavier, PhD ; Jenkins, Claire, PhD ; Thomson, Nicholas R, Prof</creator><creatorcontrib>Baker, Kate S, PhD ; Dallman, Timothy J, PhD ; Ashton, Philip M, PhD ; Day, Martin, BSc ; Hughes, Gwenda, PhD ; Crook, Paul D, MSc ; Gilbart, Victoria L, MSc ; Zittermann, Sandra, PhD ; Allen, Vanessa G, MD ; Howden, Benjamin P, Prof ; Tomita, Takehiro, PhD ; Valcanis, Mary, MPH ; Harris, Simon R, PhD ; Connor, Thomas R, PhD ; Sintchenko, Vitali, PhD ; Howard, Peter, BSc ; Brown, Jeremy D, MBBS ; Petty, Nicola K, PhD ; Gouali, Malika, PharmD ; Thanh, Duy Pham, MSc ; Keddy, Karen H, BSc (Med) ; Smith, Anthony M, PhD ; Talukder, Kaisar A, PhD ; Faruque, Shah M, PhD ; Parkhill, Julian, Prof ; Baker, Stephen, Prof ; Weill, François-Xavier, PhD ; Jenkins, Claire, PhD ; Thomson, Nicholas R, Prof</creatorcontrib><description>Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex with men (MSM), in whom transmission is an important component of shigellosis epidemiology in high-income nations. We aimed to use sophisticated subtyping and international sampling to determine factors driving shigellosis emergence in MSM linked to an outbreak in the UK. Methods We did a large-scale, cross-sectional genomic epidemiological study of shigellosis cases collected from 29 countries between December, 1995, and June 8, 2014. Focusing on an ongoing epidemic in the UK, we collected and whole-genome sequenced clinical isolates of Shigella flexneri serotype 3a from high-risk and low-risk regions, including cases associated with travel and sex between men. We examined relationships between geographical, demographic, and clinical patient data with the isolate antimicrobial susceptibility, genetic data, and inferred evolutionary relationships. Findings We obtained 331 clinical isolates of S flexneri serotype 3a, including 275 from low-risk regions (44 from individuals who travelled to high-risk regions), 52 from high-risk regions, and four outgroup samples (ie, closely related, but genetically distinct isolates used to determine the root of the phylogenetic tree). We identified a recently emerged lineage of S flexneri 3a that has spread intercontinentally in less than 20 years throughout regions traditionally at low risk for shigellosis via sexual transmission in MSM. The lineage had acquired multiple antimicrobial resistance determinants, and prevailing sublineages were strongly associated with resistance to the macrolide azithromycin. Eight (4%) of 206 isolates from the MSM-associated lineage were obtained from patients who had previously provided an isolate; these serial isolations indicated atypical infection patterns (eg, reinfection). Interpretation We identified transmission-facilitating behaviours and atypical course(s) of infection as precipitating factors in shigellosis-affected MSM. The intercontinental spread of antimicrobial-resistant shigella through established transmission routes emphasises the need for new approaches to tackle the public health challenge of sexually transmitted infections in MSM. Funding Wellcome Trust (grant number 098051).</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(15)00002-X</identifier><identifier>PMID: 25936611</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Antibiotics ; Azithromycin - therapeutic use ; Bacteriology ; Child ; Child, Preschool ; Criminal investigations ; Cross-Sectional Studies ; Disease ; Disease Outbreaks ; Drug Resistance, Bacterial - drug effects ; Dysentery, Bacillary - drug therapy ; Dysentery, Bacillary - epidemiology ; Epidemiology ; Evidence ; Female ; Genomes ; Humans ; Infant ; Infant, Newborn ; Infections ; Infectious Disease ; Infectious diseases ; Life Sciences ; Male ; Medical research ; Men ; Mens health ; Microbiology and Parasitology ; Middle Aged ; Phylogeny ; Public health ; Risk ; Santé publique et épidémiologie ; Sexually transmitted diseases ; Sexually Transmitted Diseases - drug therapy ; Sexually Transmitted Diseases - epidemiology ; Sexually Transmitted Diseases - microbiology ; Shigella flexneri - drug effects ; Shigellosis ; STD ; Studies ; Travel ; United Kingdom - epidemiology ; Young Adult</subject><ispartof>The Lancet infectious diseases, 2015-08, Vol.15 (8), p.913-921</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 2015</rights><rights>Attribution</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c655t-292ecc93f31e0299f0b0a1aa7624ebc26d6daf3df4831cc5c9ecfe9af8ddd52c3</citedby><cites>FETCH-LOGICAL-c655t-292ecc93f31e0299f0b0a1aa7624ebc26d6daf3df4831cc5c9ecfe9af8ddd52c3</cites><orcidid>0000-0001-9941-5799 ; 0000-0002-7898-7664</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S147330991500002X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25936611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://pasteur.hal.science/pasteur-02042957$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Baker, Kate S, PhD</creatorcontrib><creatorcontrib>Dallman, Timothy J, PhD</creatorcontrib><creatorcontrib>Ashton, Philip M, PhD</creatorcontrib><creatorcontrib>Day, Martin, BSc</creatorcontrib><creatorcontrib>Hughes, Gwenda, PhD</creatorcontrib><creatorcontrib>Crook, Paul D, MSc</creatorcontrib><creatorcontrib>Gilbart, Victoria L, MSc</creatorcontrib><creatorcontrib>Zittermann, Sandra, PhD</creatorcontrib><creatorcontrib>Allen, Vanessa G, MD</creatorcontrib><creatorcontrib>Howden, Benjamin P, Prof</creatorcontrib><creatorcontrib>Tomita, Takehiro, PhD</creatorcontrib><creatorcontrib>Valcanis, Mary, MPH</creatorcontrib><creatorcontrib>Harris, Simon R, PhD</creatorcontrib><creatorcontrib>Connor, Thomas R, PhD</creatorcontrib><creatorcontrib>Sintchenko, Vitali, PhD</creatorcontrib><creatorcontrib>Howard, Peter, BSc</creatorcontrib><creatorcontrib>Brown, Jeremy D, MBBS</creatorcontrib><creatorcontrib>Petty, Nicola K, PhD</creatorcontrib><creatorcontrib>Gouali, Malika, PharmD</creatorcontrib><creatorcontrib>Thanh, Duy Pham, MSc</creatorcontrib><creatorcontrib>Keddy, Karen H, BSc (Med)</creatorcontrib><creatorcontrib>Smith, Anthony M, PhD</creatorcontrib><creatorcontrib>Talukder, Kaisar A, PhD</creatorcontrib><creatorcontrib>Faruque, Shah M, PhD</creatorcontrib><creatorcontrib>Parkhill, Julian, Prof</creatorcontrib><creatorcontrib>Baker, Stephen, Prof</creatorcontrib><creatorcontrib>Weill, François-Xavier, PhD</creatorcontrib><creatorcontrib>Jenkins, Claire, PhD</creatorcontrib><creatorcontrib>Thomson, Nicholas R, Prof</creatorcontrib><title>Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex with men (MSM), in whom transmission is an important component of shigellosis epidemiology in high-income nations. We aimed to use sophisticated subtyping and international sampling to determine factors driving shigellosis emergence in MSM linked to an outbreak in the UK. Methods We did a large-scale, cross-sectional genomic epidemiological study of shigellosis cases collected from 29 countries between December, 1995, and June 8, 2014. Focusing on an ongoing epidemic in the UK, we collected and whole-genome sequenced clinical isolates of Shigella flexneri serotype 3a from high-risk and low-risk regions, including cases associated with travel and sex between men. We examined relationships between geographical, demographic, and clinical patient data with the isolate antimicrobial susceptibility, genetic data, and inferred evolutionary relationships. Findings We obtained 331 clinical isolates of S flexneri serotype 3a, including 275 from low-risk regions (44 from individuals who travelled to high-risk regions), 52 from high-risk regions, and four outgroup samples (ie, closely related, but genetically distinct isolates used to determine the root of the phylogenetic tree). We identified a recently emerged lineage of S flexneri 3a that has spread intercontinentally in less than 20 years throughout regions traditionally at low risk for shigellosis via sexual transmission in MSM. The lineage had acquired multiple antimicrobial resistance determinants, and prevailing sublineages were strongly associated with resistance to the macrolide azithromycin. Eight (4%) of 206 isolates from the MSM-associated lineage were obtained from patients who had previously provided an isolate; these serial isolations indicated atypical infection patterns (eg, reinfection). Interpretation We identified transmission-facilitating behaviours and atypical course(s) of infection as precipitating factors in shigellosis-affected MSM. The intercontinental spread of antimicrobial-resistant shigella through established transmission routes emphasises the need for new approaches to tackle the public health challenge of sexually transmitted infections in MSM. Funding Wellcome Trust (grant number 098051).</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antibiotics</subject><subject>Azithromycin - therapeutic use</subject><subject>Bacteriology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Criminal investigations</subject><subject>Cross-Sectional Studies</subject><subject>Disease</subject><subject>Disease Outbreaks</subject><subject>Drug Resistance, Bacterial - drug effects</subject><subject>Dysentery, Bacillary - drug therapy</subject><subject>Dysentery, Bacillary - epidemiology</subject><subject>Epidemiology</subject><subject>Evidence</subject><subject>Female</subject><subject>Genomes</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medical research</subject><subject>Men</subject><subject>Mens health</subject><subject>Microbiology and Parasitology</subject><subject>Middle Aged</subject><subject>Phylogeny</subject><subject>Public health</subject><subject>Risk</subject><subject>Santé publique et épidémiologie</subject><subject>Sexually transmitted diseases</subject><subject>Sexually Transmitted Diseases - drug therapy</subject><subject>Sexually Transmitted Diseases - epidemiology</subject><subject>Sexually Transmitted Diseases - microbiology</subject><subject>Shigella flexneri - drug effects</subject><subject>Shigellosis</subject><subject>STD</subject><subject>Studies</subject><subject>Travel</subject><subject>United Kingdom - epidemiology</subject><subject>Young Adult</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1v1DAQhiMEoh_wE0CRuJRDwB9xUnMAVRXQSitxAKS9WV570nXJ2luPU5H-epykFKkXfIkdP_MkM29RvKLkHSW0ef-d1i2vOJHyhIq3JC9WrZ8Uh_l1XdW1aJ_O-wU5KI4QrwmhLSX18-KACcmbhtLDYrz0CaIJPjkPPum-tA4Rds7r5IIvQ1fqO5e2MexG43wVAR0m7VOJW3cFfR_yuZzuh6ttifB7yIoUtcdd9mTDh1KXJgbECsFMynyPabDji-JZp3uEl_fP4-Lnl88_zi-q1bevl-dnq8o0QqSKSQbGSN5xCoRJ2ZEN0VTrtmE1bAxrbGN1x21Xn3JqjDASTAdSd6fWWsEMPy6qxbvVvdpHt9NxVEE7dXG2UnuNCYaoCCM1k6K9pZk_Wfh9DDcDYFK5E5M71R7CgIq2hHJKZDuhbx6h12GIucOZYi2pWyIyJRZqHkOE7uEvKFFTlmrOUk1BKSrUnKVa57rX9_ZhswP7UPU3vAx8WgDI47t1EBUaB96AdTHPWtng_vuJj48MpnfeGd3_ghHwXzcKmSKLZHJQMRvW_A-uGMdB</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Baker, Kate S, PhD</creator><creator>Dallman, Timothy J, PhD</creator><creator>Ashton, Philip M, PhD</creator><creator>Day, Martin, BSc</creator><creator>Hughes, Gwenda, PhD</creator><creator>Crook, Paul D, MSc</creator><creator>Gilbart, Victoria L, MSc</creator><creator>Zittermann, Sandra, PhD</creator><creator>Allen, Vanessa G, MD</creator><creator>Howden, Benjamin P, Prof</creator><creator>Tomita, Takehiro, PhD</creator><creator>Valcanis, Mary, MPH</creator><creator>Harris, Simon R, PhD</creator><creator>Connor, Thomas R, PhD</creator><creator>Sintchenko, Vitali, PhD</creator><creator>Howard, Peter, BSc</creator><creator>Brown, Jeremy D, MBBS</creator><creator>Petty, Nicola K, PhD</creator><creator>Gouali, Malika, PharmD</creator><creator>Thanh, Duy Pham, MSc</creator><creator>Keddy, Karen H, BSc (Med)</creator><creator>Smith, Anthony M, PhD</creator><creator>Talukder, Kaisar A, PhD</creator><creator>Faruque, Shah M, PhD</creator><creator>Parkhill, Julian, Prof</creator><creator>Baker, Stephen, Prof</creator><creator>Weill, François-Xavier, PhD</creator><creator>Jenkins, Claire, PhD</creator><creator>Thomson, Nicholas R, Prof</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><general>New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-9941-5799</orcidid><orcidid>https://orcid.org/0000-0002-7898-7664</orcidid></search><sort><creationdate>20150801</creationdate><title>Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study</title><author>Baker, Kate S, PhD ; Dallman, Timothy J, PhD ; Ashton, Philip M, PhD ; Day, Martin, BSc ; Hughes, Gwenda, PhD ; Crook, Paul D, MSc ; Gilbart, Victoria L, MSc ; Zittermann, Sandra, PhD ; Allen, Vanessa G, MD ; Howden, Benjamin P, Prof ; Tomita, Takehiro, PhD ; Valcanis, Mary, MPH ; Harris, Simon R, PhD ; Connor, Thomas R, PhD ; Sintchenko, Vitali, PhD ; Howard, Peter, BSc ; Brown, Jeremy D, MBBS ; Petty, Nicola K, PhD ; Gouali, Malika, PharmD ; Thanh, Duy Pham, MSc ; Keddy, Karen H, BSc (Med) ; Smith, Anthony M, PhD ; Talukder, Kaisar A, PhD ; Faruque, Shah M, PhD ; Parkhill, Julian, Prof ; Baker, Stephen, Prof ; Weill, François-Xavier, PhD ; Jenkins, Claire, PhD ; Thomson, Nicholas R, Prof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c655t-292ecc93f31e0299f0b0a1aa7624ebc26d6daf3df4831cc5c9ecfe9af8ddd52c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antibiotics</topic><topic>Azithromycin - therapeutic use</topic><topic>Bacteriology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Criminal investigations</topic><topic>Cross-Sectional Studies</topic><topic>Disease</topic><topic>Disease Outbreaks</topic><topic>Drug Resistance, Bacterial - drug effects</topic><topic>Dysentery, Bacillary - drug therapy</topic><topic>Dysentery, Bacillary - epidemiology</topic><topic>Epidemiology</topic><topic>Evidence</topic><topic>Female</topic><topic>Genomes</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medical research</topic><topic>Men</topic><topic>Mens health</topic><topic>Microbiology and Parasitology</topic><topic>Middle Aged</topic><topic>Phylogeny</topic><topic>Public health</topic><topic>Risk</topic><topic>Santé publique et épidémiologie</topic><topic>Sexually transmitted diseases</topic><topic>Sexually Transmitted Diseases - drug therapy</topic><topic>Sexually Transmitted Diseases - epidemiology</topic><topic>Sexually Transmitted Diseases - microbiology</topic><topic>Shigella flexneri - drug effects</topic><topic>Shigellosis</topic><topic>STD</topic><topic>Studies</topic><topic>Travel</topic><topic>United Kingdom - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baker, Kate S, PhD</creatorcontrib><creatorcontrib>Dallman, Timothy J, PhD</creatorcontrib><creatorcontrib>Ashton, Philip M, PhD</creatorcontrib><creatorcontrib>Day, Martin, BSc</creatorcontrib><creatorcontrib>Hughes, Gwenda, PhD</creatorcontrib><creatorcontrib>Crook, Paul D, MSc</creatorcontrib><creatorcontrib>Gilbart, Victoria L, MSc</creatorcontrib><creatorcontrib>Zittermann, Sandra, PhD</creatorcontrib><creatorcontrib>Allen, Vanessa G, MD</creatorcontrib><creatorcontrib>Howden, Benjamin P, Prof</creatorcontrib><creatorcontrib>Tomita, Takehiro, PhD</creatorcontrib><creatorcontrib>Valcanis, Mary, MPH</creatorcontrib><creatorcontrib>Harris, Simon R, PhD</creatorcontrib><creatorcontrib>Connor, Thomas R, PhD</creatorcontrib><creatorcontrib>Sintchenko, Vitali, PhD</creatorcontrib><creatorcontrib>Howard, Peter, BSc</creatorcontrib><creatorcontrib>Brown, Jeremy D, MBBS</creatorcontrib><creatorcontrib>Petty, Nicola K, PhD</creatorcontrib><creatorcontrib>Gouali, Malika, PharmD</creatorcontrib><creatorcontrib>Thanh, Duy Pham, MSc</creatorcontrib><creatorcontrib>Keddy, Karen H, BSc (Med)</creatorcontrib><creatorcontrib>Smith, Anthony M, PhD</creatorcontrib><creatorcontrib>Talukder, Kaisar A, PhD</creatorcontrib><creatorcontrib>Faruque, Shah M, PhD</creatorcontrib><creatorcontrib>Parkhill, Julian, Prof</creatorcontrib><creatorcontrib>Baker, Stephen, Prof</creatorcontrib><creatorcontrib>Weill, François-Xavier, PhD</creatorcontrib><creatorcontrib>Jenkins, Claire, PhD</creatorcontrib><creatorcontrib>Thomson, Nicholas R, Prof</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baker, Kate S, PhD</au><au>Dallman, Timothy J, PhD</au><au>Ashton, Philip M, PhD</au><au>Day, Martin, BSc</au><au>Hughes, Gwenda, PhD</au><au>Crook, Paul D, MSc</au><au>Gilbart, Victoria L, MSc</au><au>Zittermann, Sandra, PhD</au><au>Allen, Vanessa G, MD</au><au>Howden, Benjamin P, Prof</au><au>Tomita, Takehiro, PhD</au><au>Valcanis, Mary, MPH</au><au>Harris, Simon R, PhD</au><au>Connor, Thomas R, PhD</au><au>Sintchenko, Vitali, PhD</au><au>Howard, Peter, BSc</au><au>Brown, Jeremy D, MBBS</au><au>Petty, Nicola K, PhD</au><au>Gouali, Malika, PharmD</au><au>Thanh, Duy Pham, MSc</au><au>Keddy, Karen H, BSc (Med)</au><au>Smith, Anthony M, PhD</au><au>Talukder, Kaisar A, PhD</au><au>Faruque, Shah M, PhD</au><au>Parkhill, Julian, Prof</au><au>Baker, Stephen, Prof</au><au>Weill, François-Xavier, PhD</au><au>Jenkins, Claire, PhD</au><au>Thomson, Nicholas R, Prof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>15</volume><issue>8</issue><spage>913</spage><epage>921</epage><pages>913-921</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex with men (MSM), in whom transmission is an important component of shigellosis epidemiology in high-income nations. We aimed to use sophisticated subtyping and international sampling to determine factors driving shigellosis emergence in MSM linked to an outbreak in the UK. Methods We did a large-scale, cross-sectional genomic epidemiological study of shigellosis cases collected from 29 countries between December, 1995, and June 8, 2014. Focusing on an ongoing epidemic in the UK, we collected and whole-genome sequenced clinical isolates of Shigella flexneri serotype 3a from high-risk and low-risk regions, including cases associated with travel and sex between men. We examined relationships between geographical, demographic, and clinical patient data with the isolate antimicrobial susceptibility, genetic data, and inferred evolutionary relationships. Findings We obtained 331 clinical isolates of S flexneri serotype 3a, including 275 from low-risk regions (44 from individuals who travelled to high-risk regions), 52 from high-risk regions, and four outgroup samples (ie, closely related, but genetically distinct isolates used to determine the root of the phylogenetic tree). We identified a recently emerged lineage of S flexneri 3a that has spread intercontinentally in less than 20 years throughout regions traditionally at low risk for shigellosis via sexual transmission in MSM. The lineage had acquired multiple antimicrobial resistance determinants, and prevailing sublineages were strongly associated with resistance to the macrolide azithromycin. Eight (4%) of 206 isolates from the MSM-associated lineage were obtained from patients who had previously provided an isolate; these serial isolations indicated atypical infection patterns (eg, reinfection). Interpretation We identified transmission-facilitating behaviours and atypical course(s) of infection as precipitating factors in shigellosis-affected MSM. The intercontinental spread of antimicrobial-resistant shigella through established transmission routes emphasises the need for new approaches to tackle the public health challenge of sexually transmitted infections in MSM. Funding Wellcome Trust (grant number 098051).</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>25936611</pmid><doi>10.1016/S1473-3099(15)00002-X</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-9941-5799</orcidid><orcidid>https://orcid.org/0000-0002-7898-7664</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1473-3099 |
ispartof | The Lancet infectious diseases, 2015-08, Vol.15 (8), p.913-921 |
issn | 1473-3099 1474-4457 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_pasteur_02042957v1 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adolescent Adult Aged Antibiotics Azithromycin - therapeutic use Bacteriology Child Child, Preschool Criminal investigations Cross-Sectional Studies Disease Disease Outbreaks Drug Resistance, Bacterial - drug effects Dysentery, Bacillary - drug therapy Dysentery, Bacillary - epidemiology Epidemiology Evidence Female Genomes Humans Infant Infant, Newborn Infections Infectious Disease Infectious diseases Life Sciences Male Medical research Men Mens health Microbiology and Parasitology Middle Aged Phylogeny Public health Risk Santé publique et épidémiologie Sexually transmitted diseases Sexually Transmitted Diseases - drug therapy Sexually Transmitted Diseases - epidemiology Sexually Transmitted Diseases - microbiology Shigella flexneri - drug effects Shigellosis STD Studies Travel United Kingdom - epidemiology Young Adult |
title | Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T15%3A12%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intercontinental%20dissemination%20of%20azithromycin-resistant%20shigellosis%20through%20sexual%20transmission:%20a%20cross-sectional%20study&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Baker,%20Kate%20S,%20PhD&rft.date=2015-08-01&rft.volume=15&rft.issue=8&rft.spage=913&rft.epage=921&rft.pages=913-921&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(15)00002-X&rft_dat=%3Cproquest_hal_p%3E3773071011%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1702704705&rft_id=info:pmid/25936611&rft_els_id=1_s2_0_S147330991500002X&rfr_iscdi=true |